跳至主要内容
临床试验/NCT02902380
NCT02902380已完成不适用

The Effect of Dexmedetomidine on Neuroendocrine Stress Hormone Release and Heart Rate Variability in Patients Undergoing Major Spinal Surgery

Yonsei University1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2016年9月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
1
主要终点
Stress hormone level

研究概览

简要总结

Surgical stress induces stress hormone release and sympathetic hyperactivation. Dexmedetomidine has sympatholytic effect and attenuates stress responses. This study investigate the effect of dexmedetomidine on stress responses and autonomic nervous system balance in patients undergoing major spine surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient between 20 and 70 of age with ASA physical status Ⅰ-Ⅲ
  • patient scheduled for major spine surgery

排除标准

  • ASA physical status Ⅳ
  • congestive heart failure
  • severe hepatorenal disease
  • insulin dependent DM(diabetes mellitus)
  • cancer or metastasis
  • pregnancy
  • problem with communication

研究组 & 干预措施

Dexmedetomidine Group

Experimental

dexmedetomidine infusion (0.4 mcg/kg/h) from immediately after anesthetic induction to end of surgery

干预措施: dexmedetomidine group (Drug)

Control Group

Placebo Comparator

0.9% saline infusion

干预措施: control group (Drug)

结局指标

主要结局

Stress hormone level

时间窗: 1 hour after the end of surgery

The levels of stress hormone including epinephrine, norepinephrine, cortisol, and glucose will be measured during spinal surgery.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验